COMMUNIQUÉS West-GlobeNewswire

Survey: Nurses See Little Improvement in 2024

06/05/2024 - 16:00

Over One-Third Extremely Likely to Change Jobs DALLAS, May 06, 2024 (GLOBE NEWSWIRE) -- The majority of nurses (80%) think 2024 will be either no better or worse for nurses than 2023, according to a new survey by AMN [...]

Safety Shot Provides Shareholder Update Highlighting Significant Milestones and Progress

06/05/2024 - 15:08

JUPITER, FL, May 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (The “Company” or “Safety Shot”) today released a shareholder update to highlight the Company’s progress and strategic vision to maximize [...]

Stride Autism Centers Opens New Facility in Oak Park to Improve Autism Services in Illinois

06/05/2024 - 15:00

OAK PARK, Ill., May 06, 2024 (GLOBE NEWSWIRE) -- Stride Autism Centers ("Stride"), renowned for its mission-driven, evidence-based therapy for children with autism, announces the opening of its innovative new center in [...]

Inmagene Reports Positive Interim Results from Phase 2a Trial of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Atopic Dermatitis

06/05/2024 - 15:00

Treatment with IMG-007, the only clinical-stage nondepleting anti-OX40 monoclonal antibody (mAb), led to rapid, marked, and durable improvement of skin signs in patients with atopic dermatitis (AD). Overall, IMG-007 was [...]

Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13

06/05/2024 - 15:00

Company to Host Conference Call, May 13, 2024 at 4:30 p.m. ET SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based [...]

Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)

06/05/2024 - 15:00

-- The Centers for Medicare & Medicaid Services (CMS) released its preliminary Medicare payment determinations for the PoNS Controller and Mouthpiece -- -- Public Meeting Scheduled for May 29, 2024 -- NEWTOWN, Pa., [...]

Nova Leap Health Corp. Re-engages Acquisition Program with Closing of Strategic Acquisition in Massachusetts

06/05/2024 - 14:40

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 06, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

06/05/2024 - 14:30

- Initial data demonstrates significant reduction in distant pancreatic cancer tumor growth rate starting from three weeks after first tumor is treated with Alpha DaRT alone - Effect seen across both Panc02 and KPC [...]

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

06/05/2024 - 14:30

OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen ® ( [...]

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

06/05/2024 - 14:30

Conference Call and Webcast Scheduled for May 13, 2024 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage [...]

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06/05/2024 - 14:30

BERKELEY HEIGHTS, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]

Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call

06/05/2024 - 14:22

DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an updated issuance date for the company’s first quarter 2024 [...]

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant

06/05/2024 - 14:15

Webinar, moderated by Cantor Fitzgerald, will be held on Monday, May 13, 2024, at 2:00 p.m. ET Discussion will feature Dr. Michel Michaelides, leading expert in the field of inherited eye disease in adults and children [...]

The American Nurses Association Lights up Buildings Across the United States for Nurses Week

06/05/2024 - 14:04

Use the hashtag #NursesLightUpTheSky to snap a photo at participating locations! SILVER SPRING, MD, May 06, 2024 (GLOBE NEWSWIRE) -- Kicking off Nurses Week, the American Nurses Association (ANA) is lighting up over 50 [...]

Thousands Across Canada Unite for Annual IG Wealth Management Walk for Alzheimer’s

06/05/2024 - 14:01

Canadians in over 150 communities coast-to-coast will walk as one the weekend of May 25th in support of those living with and affected by dementia TORONTO and WINNIPEG, Manitoba, May 06, 2024 (GLOBE NEWSWIRE) -- Canada’ [...]

Cette année encore, des milliers de personnes se rassemblent pour la Marche pour l’Alzheimer IG Gestion de patrimoine

06/05/2024 - 14:01

Dans plus de 150 localités canadiennes, des gens marcheront ensemble la fin de semaine du 25 mai pour soutenir les personnes ayant un trouble neurocognitif et leurs proches. TORONTO et WINNIPEG, Manitoba, 06 mai 2024 ( [...]

HEALWELL AI Announces $16 Million Bought Deal Private Placement

06/05/2024 - 14:00

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (" HEALWELL " or the " Company ") (TSX: AIDX), a data science and AI [...]

Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1

06/05/2024 - 14:00

- Stockholders’ equity significantly surpasses the $2.5 million minimum required by Nasdaq - Company is to seek Nasdaq’s formal confirmation of compliance with equity requirements under the exchange’s Rule 5550(b)(1 [...]

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference

06/05/2024 - 14:00

SAN FRANCISCO and WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic [...]